A new study has found that nicotinamide, a drug derived from vitamin B3, can reduce the risk factor of contracting non-melanoma type skin cancers in people who have a family history of the disease. Over a 12 month period, researchers found that taking two nicotinamide pills a day reduced the development of skin cancer by 23%.
Read the full article here: Vitamin B3 derivative cuts risk of new skin cancers